SCHEMBL7703420

SCHEMBL7703420

CN1CCN(c2cccc(/C=C3\CCN(c4ccc(Cl)c(Cl)c4)C3=O)c2F)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2A1 Q16548 3/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
BCL2 P10415 1/20 0.43
MAPT P10636 1/20 0.43
ALOX12 P18054 1/20 0.43
BID P55957 1/20 0.43
RAD51 Q06609 1/20 0.43
BCL2L1 Q07817 1/20 0.43
BCL2L2 Q92843 1/20 0.43
SLC6A2 P23975 4/20 0.38
SLC6A4 P31645 4/20 0.38
DRD2 P14416 5/20 0.38
DRD3 P35462 4/20 0.38
HTR1A P08908 2/20 0.37
HTR2A P28223 2/20 0.37
DRD4 P21917 2/20 0.37
HTR2C P28335 1/20 0.37
HTR7 P34969 1/20 0.36
HTR6 P50406 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431435 0.90 BCL2A1 (0.46) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431436 0.90 BCL2A1 (0.46) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6432549 0.86 BCL2A1 (0.43) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431110 0.86 BCL2A1 (0.43) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6436217 0.85 MAPT (0.43) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6436235 0.85 MAPT (0.43) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431421 0.84 BCL2A1 (0.44) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431417 0.84 BCL2A1 (0.44) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431143 0.82 MAPT (0.44) BCL2A1ALDH1A1LMNABCL2MAPT
SCHEMBL6431142 0.82 MAPT (0.44) BCL2A1ALDH1A1LMNABCL2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020028821-A1 BENZYL(IDENE)-LACTAM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE (ANT)AGONISTS OF 5-HT1A- AND/OR 5-HT1D RECEPTORS HOWARD HARRY R (US) 2002-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028821-A1 BENZYL(IDENE)-LACTAM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE (ANT)AGONISTS OF 5-HT1A- AND/OR 5-HT1D RECEPTORS HTR1E, HTR1D, HTR1A BCL2A1 1398/4885ALDH1A1 1481/4885LMNA 1596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.